Although our study participants had almost normal levels of ALT and AST, we could not disregard that some of them had NAFLD or even non-alcoholic steatohepatitis (NASH), because liver enzymes were demonstrated to be neither sensitive nor specific in the diagnosis of chronic liver disease [45]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.